Travere Therapeutics, Inc.TVTXNASDAQ
LOADING
|||
Switch Symbol:
Operating Income Contraction
Trending higher, below historical average, strong compound growth.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-323.83M
↓ 85% below average
Average (9y)
$-175.00M
Historical baseline
Range
High:$-50.75M
Low:$-388.14M
CAGR
+22.9%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-323.83M | +16.6% |
| 2023 | $-388.14M | -21.4% |
| 2022 | $-319.81M | -60.4% |
| 2021 | $-199.43M | -13.2% |
| 2020 | $-176.16M | -76.5% |
| 2019 | $-99.81M | -24.7% |
| 2018 | $-80.04M | -48.8% |
| 2017 | $-53.79M | +7.6% |
| 2016 | $-58.21M | -14.7% |
| 2015 | $-50.75M | - |